Universität zu Köln

Olschewski, H., Behr, J., Bremer, H., Claussen, M., Douschan, P., Halank, M., Held, M., Hoeper, M. M., Holt, S., Klose, H., Krueger, S. ORCID: 0000-0002-1658-5993, Lange, T. J., Reichenberger, F., Skowasch, D., Ulrich, S., Wilkens, H. and Seeger, W. (2016). Pulmonary hypertension in grown-ups with congenital heart disease: Recommendations of the Cologne Consensus Conference 2016. Dtsch. Med. Wochenschr., 141. S. S57 - 7. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Full text not available from this repository.

Abstract

The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH) but also some aspects of pulmonary hypertension (PH) associated with chronic lung disease. The European Guidelines point out that the drugs currently used to treat patients with PAH (prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, sGC stimulators) have not been sufficiently investigated in other forms of PH. Therefore, the European Guidelines do not recommend the use of these drugs in patients with chronic lung disease and PH. This recommendation, however, is not always in agreement with medical ethics as physicians feel sometimes inclined to treat other form of PH which may affect quality of life and survival of these patients in a similar manner. To this end, it is crucial to consider the severity of both PH and the underlying lung disease. In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany, to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of PH in patients with chronic lung disease. The recommendations of this working group are summarized in the present paper.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Olschewski, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Behr, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Bremer, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Claussen, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Douschan, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Halank, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Held, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hoeper, M. M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Holt, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Klose, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Krueger, S. UNSPECIFIED orcid.org/0000-0002-1658-5993 UNSPECIFIED Lange, T. J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Reichenberger, F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Skowasch, D. UNSPECIFIED UNSPECIFIED UNSPECIFIED Ulrich, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Wilkens, H. UNSPECIFIED UNSPECIFIED UNSPECIFIED Seeger, W. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-259485
DOI:	10.1055/s-0042-114528
Journal or Publication Title:	Dtsch. Med. Wochenschr.
Volume:	141
Page Range:	S. S57 - 7
Date:	2016
Publisher:	GEORG THIEME VERLAG KG
Place of Publication:	STUTTGART
ISSN:	1439-4413
Language:	German
Faculty:	Faculty of Mathematics and Natural Sciences
Divisions:	Faculty of Mathematics and Natural Sciences > Department of Biology > Botanical Institute
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language OBSTRUCTIVE LUNG-DISEASE; CONTROLLED-TRIAL; DIFFUSION CAPACITY; EMPHYSEMA SYNDROME; CLINICAL CHARACTERISTICS; PROGNOSTIC-FACTORS; ASPIRE REGISTRY; FIBROSIS; COPD; PRESSURE Multiple languages Medicine, General & Internal Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/25948